SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Instruments Regulatory News (OXIG)

Share Price Information for Oxford Instruments (OXIG)

Share Price is delayed by 15 minutes
Get Live Data
2,878.00    130.00 (4.73%)
Bid:
2,846.00
Ask:
2,862.00
Spread: 16.00 (0.562%)
Market Cap: £1.59b
OXIG Live PriceLast checked at - London Stock Exchange

Intraday Oxford Instruments Share Chart

AGM Statement

11 Sep 2012 07:00

RNS Number : 9360L
Oxford Instruments PLC
11 September 2012
 



Release time & date: 7:00am 11/09/2012

 

Oxford Instruments plc Chairman's AGM Statement 2012

 

 

Oxford Instruments plc, a leading provider of high technology tools and systems for industry and research, is holding its annual general meeting today in which the Chairman, Nigel Keen will make the following statement:

 

"In June 2011 we outlined our 14 cubed objective to achieve a compound annual revenue growth rate of 14% and a return on sales of 14% by the financial year ending March 2014. It is anticipated that this objective will be achieved predominantly through organic growth and continuing internal efficiency improvements, augmented by targeted bolt on acquisitions.

 

The year to March 2012 was the first year of the 14 Cubed plan and we reported sales growth of 29% split equally between organic growth and the three bolt-on acquisitions we made to strengthen our competitive position. Return on sales also improved in line with our targets, increasing from 10.7% to 12.5%

 

In the current year our Nanotechnology Tools business has made good progress as Oxford Instruments' customers use our equipment to work at the frontiers of science and improve the efficiency of high technology production facilities. The launch of our new XMax large area detector in August has further consolidated our position as a leading provider of advanced material analysis equipment.

 

Over the same period our Industrial division has also continued to trade in line with expectations. Our customers use Oxford Instruments' equipment to implement high-tech manufacturing strategies for advanced materials and products. Sales have been helped by the launch of the new X-MET 7500 hand held material analyser which is helping to grow our market share.

 

The Service division has performed well providing aftermarket service to the installed base of Oxford Instruments equipment. The Platinum Medical Imaging business acquired in November last year has integrated well and further strengthened our offering in this area.

 

Order intake from our research markets remains good although as expected there has been some softness in our industrial markets. Despite the ongoing uncertainties in global economies, we believe the diversity of our activities combined with our strong pipe-line of new products will continue to provide good growth opportunities for the Group.

 

The Board anticipates that Oxford Instruments will continue to make progress in line with our expectations for the financial year."

 

  

- Ends -

Issued for and on behalf of Oxford Instruments plc

 

 

For further information please contact:

 

Oxford Instruments Plc

+44 (0)1865 393200

Jonathan Flint - Chief Executive

Kevin Boyd - Group Finance Director

MHP Communications

+44 (0)20 3128 8100

Rachel Hirst / Ian Payne

 

Notes to Editors  

 

About Oxford Instruments plc

Oxford Instruments designs, supplies and supports high-technology tools and systems with a focus on research and industrial applications. It provides solutions needed to advance fundamental physics research and its transfer into commercial nanotechnology applications. Innovation has been the driving force behind Oxford Instruments' growth and success for over 50 years, and its strategy is to effect the successful commercialisation of these ideas by bringing them to market in a timely and customer-focused fashion. 

The first technology business to be spun out from Oxford University over fifty years ago, Oxford Instruments is now a global company with over 1900 staff worldwide and is listed on the FTSE250 index of the London Stock Exchange (OXIG).  Its objective is to be the leading provider of new generation tools and systems for the research and industrial sectors.

This involves the combination of core technologies in areas such as low temperature, high magnetic field and ultra high vacuum environments, Nuclear Magnetic Resonance, X-ray, electron and optical based metrology, and advanced growth, deposition and etching.

Oxford Instruments aims to pursue responsible development and deeper understanding of our world through science and technology. Its products, expertise, and ideas address global issues such as energy, environment, security and health.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMURUNRUOAKAAR
Date   Source Headline
4th Feb 20267:00 amPRNTransaction in Own Shares
3rd Feb 20267:00 amPRNTransaction in Own Shares
2nd Feb 20262:53 pmPRNTotal Voting Rights
2nd Feb 20267:59 amPRNTransaction in Own Shares
30th Jan 20267:00 amPRNTransaction in Own Shares
29th Jan 20267:00 amPRNTransaction in Own Shares
28th Jan 20267:00 amPRNTransaction in Own Shares
27th Jan 20267:00 amPRNTransaction in Own Shares
26th Jan 20267:00 amPRNTransaction in Own Shares
23rd Jan 20264:26 pmPRNHolding(s) in Company
22nd Jan 20267:00 amPRNTransaction in Own Shares
21st Jan 20267:00 amPRNTransaction in Own Shares
20th Jan 20267:00 amPRNTransaction in Own Shares
19th Jan 20269:39 amPRNHolding(s) in Company
15th Jan 20267:00 amRNSTrading Update
15th Jan 20267:00 amPRNTransaction in Own Shares
14th Jan 20262:15 pmPRNHolding(s) in Company
13th Jan 20264:15 pmPRNHolding(s) in Company
13th Jan 20267:00 amPRNTransaction in Own Shares
12th Jan 20267:00 amPRNTransaction in Own Shares
9th Jan 20267:00 amPRNTransaction in Own Shares
8th Jan 20267:00 amPRNTransaction in Own Shares
7th Jan 20267:00 amPRNTransaction in Own Shares
6th Jan 20267:00 amPRNTransaction in Own Shares
2nd Jan 202612:44 pmPRNBlock listing Interim Review
2nd Jan 202612:26 pmPRNTotal Voting Rights
23rd Dec 20253:32 pmRNSDirector/PDMR Shareholding
23rd Dec 20253:32 pmPRNDirector/PDMR Shareholding
22nd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 20257:00 amPRNTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amPRNTransaction in Own Shares
18th Dec 20257:00 amPRNTransaction in Own Shares
17th Dec 20253:16 pmPRNHolding(s) in Company
17th Dec 20257:00 amPRNTransaction in Own Shares
16th Dec 20257:00 amPRNTransaction in Own Shares
15th Dec 20257:00 amPRNTransaction in Own Shares
12th Dec 20257:00 amPRNTransaction in Own Shares
11th Dec 20257:00 amPRNTransaction in Own Shares
10th Dec 20257:00 amPRNTransaction in Own Shares
9th Dec 20257:00 amPRNTransaction in Own Shares
8th Dec 20252:37 pmPRNHolding(s) in Company
3rd Dec 20257:00 amPRNTransaction in Own Shares
2nd Dec 20257:00 amPRNTransaction in Own Shares
1st Dec 202510:37 amPRNTotal Voting Rights
1st Dec 20257:00 amPRNTransaction in Own Shares
28th Nov 20257:00 amPRNTransaction in Own Shares
27th Nov 20257:00 amPRNTransaction in Own Shares
26th Nov 20257:00 amPRNTransaction in Own Shares
25th Nov 20257:00 amPRNTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.